ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

Comments Invited On Centers Program

November 27, 1987

NCI-Approved Trials Listed

March 30, 2007

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

NCI To Fund 22 Of 38 Clinical Investigator Applications, Five Of Them To Surgeons

June 1, 1984

In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981

May 29, 1981